Neurological adverse events of PD-1/PD-L1 immune checkpoint inhibitors in clinical trials: A meta-analysis Yanting Zhou; Hansong Yu; Hongyan Li;

ß-glucan combined with PD-1/PD-L1 checkpoint blockade suppresses pancreatic tumor growth after ablation therapy Shengbo Wu; Xixi Sun; Han Wang; Jiayuan Chai; Bin Huang;

TRIB3 is a biomarker of poor prognosis in laryngeal squamous cell carcinoma and may affect tumor development through PI3K / AKT / mTOR pathway Runsheng Yuan; Zhongqiang Cheng; Xiaodong Zhan;